For thirty years, creatine research was almost exclusively performed on men. The resulting headlines — "creatine for bigger muscles" — created a cultural perception that it was a supplement for male bodybuilders.
The emerging data suggests we got this backwards. Female athletes may have more to gain from creatine supplementation than their male counterparts.
---
A landmark 2022 scoping review by Lobo et al. in the Journal of the International Society of Sports Nutrition synthesised the evidence specific to women and creatine. One finding stands out: women have 70–80% lower endogenous creatine stores than men, relative to their lean mass. This is partly explained by lower habitual dietary creatine intake (less red meat), partly by oestrogen's complex interaction with the creatine transporter SLC6A8.
Lower baseline stores mean a larger absolute deficit — and potentially a larger response to supplementation. Galvan et al. (2021) confirmed this: female participants achieved proportionally greater phosphocreatine (PCr) resaturation relative to baseline compared to males in the same loading protocol.
---
Beyond muscle performance, the cognitive case for creatine in women is compelling. Brain phosphocreatine underpins rapid ATP resynthesis in neurons — especially during cognitive load, sleep deprivation, and stress. Benton and Donohoe (2011) demonstrated improved memory performance with creatine supplementation in vegetarians and omnivores. Women, who show higher prevalence of depression, anxiety, and cognitive fatigue, may find particular benefit here.
The menstrual cycle adds another layer. Oestrogen upregulates creatine transporter expression in the follicular phase, meaning creatine uptake into muscle and brain tissue may peak mid-cycle. Preliminary data suggest loading during the follicular phase (days 1–14) may optimise tissue saturation — an area of active research that Lobo's group has called a priority for clinical trials.
---
For post-menopausal athletes, the rationale is even stronger. Smith-Ryan et al. (2022) showed that creatine combined with resistance training significantly attenuated lean mass loss and maintained bone mineral density in post-menopausal women. The mechanism involves creatine's role in supporting myosin heavy chain IIx preservation — fast-twitch fibres that are disproportionately lost with age and oestrogen decline.
Progestins — particularly synthetic progestins in hormonal contraceptives — may impair creatine transporter function in some tissues, a consideration for athletes on the pill. This remains an area needing direct investigation, but it reinforces the importance of individualised assessment.
---
Practically, the protocol is the same as for male athletes: 3–5g/day of creatine monohydrate as a maintenance dose produces full phosphocreatine resaturation within 3–4 weeks without a loading phase and its associated water retention. There is no evidence that a lower dose is appropriate for women — the 3g/day recommendation some coaches suggest is not supported by pharmacokinetic data.
Concerns about weight gain in female athletes deserve addressing: the initial 1–2kg increase reflects intracellular water retention, not fat or functional body mass changes. In weight-class sports, timing creatine to off-season or non-competition periods is pragmatic rather than necessary.
For female athletes wanting to calculate an optimal creatine loading and maintenance dose based on body weight and training frequency, the tool at winsport.uk/tools/nutrition/creatine-loading-calculator provides personalised estimates grounded in current ISSN position stand recommendations.
Why do you think female-specific creatine research took so long to emerge — is it simply researcher bias, or are there other barriers?